| HOME >> MEDICINE >> TECHNOLOGY |
118,975,995LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities:Short-term bank loans6,009,912
-Accounts payable7,219,825
5,362,155Accrued payroll and employee benefits2,807,179
2,393,700Customer deposits881,656
687,275Accrued and other liabilities3,142,479
3,057,445Amounts due to affiliated companies50,153
58,338Income taxes payable1,713,575
1,477,212Total current liabilities21,824,779
13,036,125Deferred tax liabilities43,204
42,699Total liabilities21,867,983
13,078,824Commitments and contingencies-
-Stockholders' equity:Common stock, par value $0.001 per share; authorized 247,500,000, issued and outstanding December 31, 2010 -24,130,247 shares; September 30, 2010 - 23,950,740 shares24,131
23,951Additional paid-in capital40,435,620
40,154,494Retained earnings52,058,278
48,730,034Statutory reserves4,585,731
4,585,731Accumulated other comprehensive income 13,556,996
12,302,762Total Winner Medical Group Inc stockholders' equity110,660,756
105,796,972Non-controlling interests 113,187
100,199Total equity110,773,943
105,897,171
Total liabilities and equity132,641,926
118,975,995Winner Medical Group Inc. Non-GAAP ReconciliationDecember 31,20102009US$US$Net income attributable to Winner Medical Group Inc. (GAAP)3,328,244
3,920,711Share-based compensation 281,306
302,903Adjusted net income attributable to Winner Medical Group Inc. (Non-GAAP)3,609,550
4,223,614Earnings per share (GAAP)- Basic 0.14
0.18- Diluted 0.14
0.17Adjusted earnings per share (Non-GAAP)- Basic 0.15
0.19- Diluted 0.15
0.19Weighted average ordinary shares outstanding- Basic24,116,281
22,363,740- Diluted 24,498,551
22,473,167Selling, general and administrative expenses (GAAP)6,056,065
5,323,721Share-based compensation 281,306
<| SOURCE Winner Medical Group Inc. Copyright©2010 PR Newswire. All rights reserved |